Clinical Trial Update: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) [NA]

View source ↗

Summary

This entry describes the SALOME clinical trial studying follow-up of patients with uveal melanoma to adapt to relapse risk; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Snippet

Sponsor: Institut Curie | Conditions: Uveal Melanoma | NA | Status: RECRUITING